Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

A federal judge in Texas handed Novo Nordisk (NVO) a big win late Thursday in its battle against cheaper versions of its ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

The first step of setting up a new device starts with cleaning up your old phone. If you’re planning on trading in your old ...

Like hermit crabs, these caterpillars carry their cases with them as they move before emerging from them as full grown moths.

A WOMAN who weighed 12st 10lbs and was a size 16 decided to try the weight loss jab after struggling to stick to diets, but things weren’t as perfect as she’d hoped. Kathleen Smith, ...

Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...

Kathleen Smith, 40, dropped three sizes on Mounjaro but says it wasn't 'worth it' after she lost her hair and it left her ...

Drug distributors like Cardinal Health, Cencora and McKesson will play a key role in the drug supply chain, improving patient ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.